2024 | Long-Term Outcomes of Neoadjuvant Therapy Versus Upfront Surgery for Resectable Pancreatic Ductal Adenocarcinoma
| CANCER MEDICINE |
2024 | Gadoxetic acid-enhanced MRI for the detection of liver metastases from melanoma
| PLOS ONE |
2024 | Deep-Transfer-Learning-Based Natural Language Processing of Serial Free-Text Computed Tomography Reports for Predicting Survival of Patients With Pancreatic Cancer | JCO CLINICAL CANCER INFORMATICS |
2024 | Preoperative Prediction of Microvascular Invasion with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients with Single Hepatocellular Carcinoma: The Implication of Surgical Decision on the Extent of Liver Resection | LIVER CANCER |
2024 | Radiomics model versus 2017 revised international consensus guidelines for predicting malignant intraductal papillary mucinous neoplasms | EUROPEAN RADIOLOGY |
2024 | Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trial
| BRITISH JOURNAL OF CANCER |
2024 | Risk Stratification of Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy
| CANCER RESEARCH AND TREATMENT |
2023 | A preoperative scoring system to predict lymph node metastasis in intrahepatic cholangiocarcinoma | HEPATOLOGY INTERNATIONAL |
2023 | Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology
| KOREAN JOURNAL OF RADIOLOGY |
2023 | Steatotic hepatocellular carcinoma: Association of MRI findings to underlying liver disease and clinicopathological characteristics | LIVER INTERNATIONAL |
2023 | Diagnostic Performance of LI-RADS v2018 versus KLCA-NCC 2018 Criteria for Hepatocellular Carcinoma Using Magnetic Resonance Imaging with Hepatobiliary Agent: A Systematic Review and Meta-Analysis of Comparative Studies
| GUT AND LIVER |
2023 | Comparison of imaging findings of macrotrabecular-massive hepatocellular carcinoma using CT and gadoxetic acid-enhanced MRI | EUROPEAN RADIOLOGY |
2023 | Optimal imaging criteria and modality to determine Milan criteria for the prediction of post-transplant HCC recurrence after locoregional treatment | EUROPEAN RADIOLOGY |
2022 | Regional lymph node metastasis detected on preoperative CT and/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection
| SCIENTIFIC REPORTS |
2022 | Editorial for "Multiparametric MRI-Based Radiomic Signature for Preoperative Evaluation of Overall Survival in Intrahepatic Cholangiocarcinoma After Partial Hepatectomy" | JOURNAL OF MAGNETIC RESONANCE IMAGING |
2022 | Evaluation of the 8th Edition AJCC Staging System for the Clinical Staging of Pancreatic Cancer
| CANCERS |
2022 | A New Reporting System for Diagnosis of Hepatocellular Carcinoma in Chronic Hepatitis B With Clinical and Gadoxetic Acid-Enhanced MRI Features | JOURNAL OF MAGNETIC RESONANCE IMAGING |
2022 | Retrospective Evaluation of Treatment Response in Patients with Nonmetastatic Pancreatic Cancer Using CT and CA 19-9 | RADIOLOGY |
2022 | MRI-diagnosis of category LR-M observations in the Liver Imaging Reporting and Data System v2018: a systematic review and meta-analysis | EUROPEAN RADIOLOGY |
2022 | Preoperative magnetic resonance imaging-based prognostic model for mass-forming intrahepatic cholangiocarcinoma | LIVER INTERNATIONAL |
2022 | A multi-institutional, single-arm, phase II trial of neoadjuvant modified-FOLFIRINOX for resectable pancreatic ductal adenocarcinoma | JOURNAL OF CLINICAL ONCOLOGY |
2022 | CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis | RADIOLOGY |
2022 | Contrast-enhanced ultrasound Liver Imaging Reporting and Data System category M: a systematic review and meta-analysis
| ULTRASONOGRAPHY |
2022 | Response to Neoadjuvant Therapy and Prognosis in Patients with Resectable Pancreatic Cancer: A Propensity Score Matching Analysis
| GUT AND LIVER |
2021 | Clinical Staging of Mass-Forming Intrahepatic Cholangiocarcinoma: Computed Tomography Versus Magnetic Resonance Imaging
| HEPATOLOGY COMMUNICATIONS |
2021 | Diagnostic Performance of Liver Imaging Reporting and Data System Version 2017 Versus Version 2018 for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Comparative Studies | JOURNAL OF MAGNETIC RESONANCE IMAGING |
2021 | Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma based on clinical, radiologic, and radiomics features | EUROPEAN RADIOLOGY |
2021 | Systematic review and meta-analysis of diagnostic performance of CT imaging for assessing resectability of pancreatic ductal adenocarcinoma after neoadjuvant therapy: importance of CT criteria | ABDOMINAL RADIOLOGY |
2021 | Characteristics and Early Recurrence of Hepatocellular Carcinomas Categorized as LR-M: Comparison with Those Categorized as LR-4 or 5 | JOURNAL OF MAGNETIC RESONANCE IMAGING |
2021 | Korean clinical practice guideline for pancreatic cancer 2021: A summary of evidence-based, multi-disciplinary diagnostic and therapeutic approaches | PANCREATOLOGY |
2021 | Should Threshold Growth Be Considered a Major Feature in the Diagnosis of Hepatocellular Carcinoma Using LI-RADS?
| KOREAN JOURNAL OF RADIOLOGY |
2021 | Hepatobiliary phase signal intensity: A potential method of diagnosing HCC with atypical imaging features among LR-M observations
| PLOS ONE |
2021 | LI-RADS treatment response algorithm for detecting incomplete necrosis in hepatocellular carcinoma after locoregional treatment: a systematic review and meta-analysis using individual patient data | ABDOMINAL RADIOLOGY |
2021 | Effectiveness of Hepatocellular Carcinoma Surveillance and an Optimal Surveillance Interval: Nationwide Cohort of Korea
| YONSEI MEDICAL JOURNAL |
2021 | LI-RADS Major Features on MRI for Diagnosing Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis | JOURNAL OF MAGNETIC RESONANCE IMAGING |
2021 | Comparison of the current guidelines for diagnosing hepatocellular carcinoma using gadoxetic acid-enhanced magnetic resonance imaging | EUROPEAN RADIOLOGY |
2021 | Noninvasive evaluation of liver fibrosis: comparison of the stretched exponential diffusion-weighted model to other diffusion-weighted MRI models and transient elastography | EUROPEAN RADIOLOGY |
2021 | A Case Report of Cholangiocarcinoma Arising from a Biliary Adenofibroma: Radiologic Findings and Review of Literature
| Journal of the Korean Society of Radiology(대한영상의학회지) |
2021 | Subcentimeter hepatocellular carcinoma in treatment-naïve patients: noninvasive diagnostic criteria and tumor staging on gadoxetic acid-enhanced MRI | EUROPEAN RADIOLOGY |
2021 | Radiologic Evaluation for Resectability of Pancreatic Adenocarcinoma
| Journal of the Korean Society of Radiology(대한영상의학회지) |
2021 | Extended application of subtraction arterial phase imaging in LI-RADS version 2018: a strategy to improve the diagnostic performance for hepatocellular carcinoma on gadoxetate disodium-enhanced MRI | EUROPEAN RADIOLOGY |
2021 | Prognostic factors in patients with locally advanced or borderline resectable pancreatic ductal adenocarcinoma: chemotherapy vs. chemoradiotherapy | ABDOMINAL RADIOLOGY |
2021 | A prospective study on the use of ultralow-dose computed tomography with iterative reconstruction for the follow-up of patients liver and renal abscess
| PLOS ONE |
2021 | Initial experience of irreversible electroporation for locally advanced pancreatic cancer in a Korean population | ACTA RADIOLOGICA |
2021 | Liver MRI with amide proton transfer imaging: feasibility and accuracy for the characterization of focal liver lesions | EUROPEAN RADIOLOGY |
2021 | The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma
| KOREAN JOURNAL OF RADIOLOGY |
2021 | Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications | JOURNAL OF HEPATOLOGY |
2020 | MRI Ancillary Features for LI-RADS Category 3 and 4 Observations: Improved Categorization to Indicate the Risk of Hepatic Malignancy | AMERICAN JOURNAL OF ROENTGENOLOGY |
2020 | Gadoxetic acid-enhanced MRI of hepatocellular carcinoma: Diagnostic performance of category-adjusted LR-5 using modified criteria
| PLOS ONE |
2020 | The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization
| GUT AND LIVER |